Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Lancet, The | 2020 | 25.2K |
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Lancet, The | 2020 | 15K |
A novel coronavirus outbreak of global health concern | Lancet, The | 2020 | 3.7K |
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 | New England Journal of Medicine | 2020 | 3.3K |
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial | Lancet, The | 2020 | 2.1K |
SARS-CoV-2 and viral sepsis: observations and hypotheses | Lancet, The | 2020 | 646 |
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study | Chinese Medical Journal | 2020 | 619 |
On the use of corticosteroids for 2019-nCoV pneumonia | Lancet, The | 2020 | 399 |
Fangcang shelter hospitals: a novel concept for responding to public health emergencies | Lancet, The | 2020 | 376 |
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines | Thrombosis and Haemostasis | 2020 | 221 |
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells | Nature Communications | 2020 | 151 |
Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China | European Journal of Clinical Nutrition | 2020 | 149 |
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD | New England Journal of Medicine | 2020 | 121 |
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem Cells | Cell | 2020 | 93 |
Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study | Journal of Medical Virology | 2020 | 89 |
Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019 | Chinese Medical Journal | 2020 | 84 |
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection | Journal of Infectious Diseases | 2020 | 73 |
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine | Thrombosis and Haemostasis | 2020 | 73 |
Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study | Lancet Respiratory Medicine,the | 2020 | 66 |
Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus | Critical Care Medicine | 2020 | 59 |
Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19) | Chronic Diseases and Translational Medicine | 2020 | 55 |
Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society | Clinical Infectious Diseases | 2020 | 49 |
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial | Trials | 2020 | 43 |
Dapk1 improves inflammation, oxidative stress and autophagy in LPS-induced acute lung injury via p38MAPK/NF-κB signaling pathway | Molecular Immunology | 2020 | 41 |
Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China | Journal of Medical Virology | 2020 | 39 |